The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received…
Less than two weeks after raising $22.5 million, San Diego cancer drug developer Impact Biomedicines has closed a deal for up to $90 million more. The…
Breast Cancer expert DR Carol-Anne Benn says most lumps are not cancerous but it is very important to get them checked anyway. JOHANNESBURG – Breast…